We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACAB market cap is 91.47M. The company's latest EPS is USD 0.3455 and P/E is 32.42.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -588k | -538k | -420k | -315k | -393k |
Net Income | 1.46M | 2.07M | 803k | -44k | -7k |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -2k | -2.05M | -1.67M |
Net Income | -2k | 887k | 2.82M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Assets | 310.56M | 313.65M | 38.44M | 37.52M | 37.37M |
Total Liabilities | 12.64M | 13.66M | 16.89M | 16.01M | 45.89M |
Total Equity | -11.18M | -11.66M | -14.81M | -15.06M | -15.82M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 361k | 310.56M | 37.37M |
Total Liabilities | 338k | 12.64M | 45.89M |
Total Equity | 23k | -11.18M | -15.82M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Operating | -1.19M | -97k | -227k | -1.51M | -3.85M |
Investing | -305.67M | N/A | 278.6M | 278.6M | 278.44M |
Financing | 307.25M | N/A | -276.54M | -276.54M | -274.73M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | -1.19M | -3.85M |
Investing | N/A | -305.67M | 278.44M |
Financing | N/A | 307.25M | -274.73M |
Market Cap | 91.47M |
Price to Earnings Ratio | 32.42 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 345.68 |
Price to Book Ratio | -10.73 |
Dividend Yield | - |
Shares Outstanding | 8.17M |
Average Volume (1 week) | 3.58k |
Average Volume (1 Month) | 4.62k |
52 Week Change | 6.16% |
52 Week High | 13.20 |
52 Week Low | 10.54 |
Spread (Intraday) | 0.52 (4.49%) |
Company Name | Atlantic Coastal Acquisition Corporation II |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https:// |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions